Vir Biotechnology (VIR) Common Equity (2018 - 2026)
Vir Biotechnology (VIR) reported Common Equity of $982.49 million for Q2 2026, up 3.7% from $947.47 million a year earlier and up 20.9% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Vir Biotechnology posted Common Equity of $765.28 million, down 33.5% from FY2024.
- Common Equity has declined for three consecutive years, though with a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- By year, Common Equity came in at $1.15 billion in FY2024 (-27.7%), $1.59 billion in FY2023 (-23.5%), $2.08 billion in FY2022 (+45.1%) and $1.43 billion in FY2021 (+99.7%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity since Q1 2025.
- Year over year, Common Equity gained in 1 of the last eight quarters, with an average decline of 26.0%.
- The high point for year-over-year Common Equity in five years was Q1 2022 (growth of 207.4%); the low point was Q3 2025 (a decline of 35.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $812.77 million (Q1 2026), $765.28 million (Q4 2025) and $796.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn | 982.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 982.49 Mn |
| Mar 31, 2026 | 812.77 Mn |
| Dec 31, 2025 | 765.28 Mn |
| Sep 30, 2025 | 796.10 Mn |
| Jun 30, 2025 | 947.47 Mn |
| Mar 31, 2025 | 1.04 Bn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 30, 2024 | 1.24 Bn |
| Jun 30, 2024 | 1.43 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.68 Bn |
| Jun 30, 2023 | 1.81 Bn |
| Mar 31, 2023 | 1.97 Bn |
| Dec 31, 2022 | 2.08 Bn |
| Sep 30, 2022 | 2.15 Bn |
| Jun 30, 2022 | 1.95 Bn |
| Mar 31, 2022 | 2.00 Bn |
| Dec 31, 2021 | 1.43 Bn |
| Sep 30, 2021 | 876.27 Mn |
API Access
Vir Biotechnology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();